Skip to Main Content
Yale Medical Oncology
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Ste 7th Floor Multispecialty Care Center
New Haven, CT 06511
  • Yale Medical Oncology
    Smilow Cancer Hospital at Yale New Haven
    35 Park Street, Ste 7th Floor Multispecialty Care Center
    New Haven, CT 06511

Stuart Seropian, MD

Hematologic Oncology, Leukemia & Lymphoma, Hematology
Telehealth is available
Learn more about telehealth
Patient type treated
Adult
Accepting new patients
Yes
Referral required
From patients or physicians
Board Certified in
Internal Medicine and Medical Oncology

Biography

Stuart Seropian, MD, is a medical oncologist who specializes in treating patients with blood cancers, including acute and chronic leukemia, non-Hodgkin’s lymphoma, and multiple myeloma. Dr. Seropian also sees patients with non-cancerous bone marrow disorders, including aplastic anemia. He is director of the adult Stem Cell Transplant program and co-director of the CAR T-cell Therapy Program for adults.

In medical school, Dr. Seropian enjoyed studying the biology of cancer and wanted to provide long-term patient care, which led to his pursuing medical oncology. “I have patients who see me as their primary care physician—as the doctor most responsible for their long-term care,” Dr. Seropian says. “Patients will say they’ve experienced a physician who had one foot out the door before all questions were answered. But the relationship with the patient is vital for cancer treatment.”

During his career, Dr. Seropian has witnessed treatment options for patients with blood cancers improve by leaps and bounds, from chemotherapy to the personalized CAR T-cell and stem cell transplantation therapies.

“The general view among the public is that cancer is terminal,” Dr. Seropian says. “People are always surprised to hear that cure rates [for certain cancers] range from 30 to 65 percent.”

He points out that a transplant physician is one of many providers of care in a large cast, which includes other physician subspecialists, nurse practitioners, nurses, coordinators, laboratory physicians and technicians. “Patients who come here are cared for by a family of people,” he says.

Dr. Seropian is an associate professor of medicine (hematology) at Yale School of Medicine.

Titles

  • Professor of Internal Medicine (Hematology)
  • Acting Director, Stem Cell Transplantation
  • Chairman, Car-T Cell Joint Steering Committee
  • Director, Unrelated Donor Transplant Program, Stem Cell Transplantation
  • Co-Director, Immune Effector Cell Therapy
  • Co-Director, Adult CAR T-Cell Therapy Program

Education & Training

  • Resident
    Yale-New Haven Hospital (1994)
  • Intern
    Yale-New Haven Hospital (1992)
  • MD
    George Washington University (1991)
  • BS
    Tufts University (1984)

Additional Information

Locations
Yale Medical Oncology
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Ste 7th Floor Multispecialty Care Center
New Haven, CT 06511
  • Yale Medical Oncology
    Smilow Cancer Hospital at Yale New Haven
    35 Park Street, Ste 7th Floor Multispecialty Care Center
    New Haven, CT 06511

Biography

Stuart Seropian, MD, is a medical oncologist who specializes in treating patients with blood cancers, including acute and chronic leukemia, non-Hodgkin’s lymphoma, and multiple myeloma. Dr. Seropian also sees patients with non-cancerous bone marrow disorders, including aplastic anemia. He is director of the adult Stem Cell Transplant program and co-director of the CAR T-cell Therapy Program for adults.

In medical school, Dr. Seropian enjoyed studying the biology of cancer and wanted to provide long-term patient care, which led to his pursuing medical oncology. “I have patients who see me as their primary care physician—as the doctor most responsible for their long-term care,” Dr. Seropian says. “Patients will say they’ve experienced a physician who had one foot out the door before all questions were answered. But the relationship with the patient is vital for cancer treatment.”

During his career, Dr. Seropian has witnessed treatment options for patients with blood cancers improve by leaps and bounds, from chemotherapy to the personalized CAR T-cell and stem cell transplantation therapies.

“The general view among the public is that cancer is terminal,” Dr. Seropian says. “People are always surprised to hear that cure rates [for certain cancers] range from 30 to 65 percent.”

He points out that a transplant physician is one of many providers of care in a large cast, which includes other physician subspecialists, nurse practitioners, nurses, coordinators, laboratory physicians and technicians. “Patients who come here are cared for by a family of people,” he says.

Dr. Seropian is an associate professor of medicine (hematology) at Yale School of Medicine.

Titles

  • Professor of Internal Medicine (Hematology)
  • Acting Director, Stem Cell Transplantation
  • Chairman, Car-T Cell Joint Steering Committee
  • Director, Unrelated Donor Transplant Program, Stem Cell Transplantation
  • Co-Director, Immune Effector Cell Therapy
  • Co-Director, Adult CAR T-Cell Therapy Program

Education & Training

  • Resident
    Yale-New Haven Hospital (1994)
  • Intern
    Yale-New Haven Hospital (1992)
  • MD
    George Washington University (1991)
  • BS
    Tufts University (1984)

Additional Information

Locations
Yale Medical Oncology
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Ste 7th Floor Multispecialty Care Center
New Haven, CT 06511
  • Yale Medical Oncology
    Smilow Cancer Hospital at Yale New Haven
    35 Park Street, Ste 7th Floor Multispecialty Care Center
    New Haven, CT 06511
Yale Medical Oncology
Smilow Cancer Hospital at Yale New Haven
35 Park Street, Ste 7th Floor Multispecialty Care Center
New Haven, CT 06511
  • Yale Medical Oncology
    Smilow Cancer Hospital at Yale New Haven
    35 Park Street, Ste 7th Floor Multispecialty Care Center
    New Haven, CT 06511